Prominent adverse effects of thalidomide in primary Sjögren's syndrome
✍ Scribed by Pillemer, Stanley R. ;Leakan, Rose Anne ;Sankar, Vidya ;Manny, Joan ;Baum, Bruce J. ;Smith, Janine ;Chaudhry, Usha ;Fox, Philip C. ;Radfar, Lida ;Ligier, Sophie ;Brennan, Michael T.
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 43 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Objective: There is no effective treatment for patients with primary sjögren's syndrome (ss). since tumor necrosis factor alpha (tnf alpha) could be a key element in the pathogenesis of primary ss, we conducted a multicenter, randomized, double-blind, placebo-controlled trial to evaluate the eff
## Abstract ## Objective Primary Sjögren's syndrome (SS) is an autoimmune disease characterized by activation of minor salivary gland (MSG) epithelial cells and B and T lymphocytic infiltrates. These findings have long encouraged the hypothesis that a persistent viral infection of the MSG epitheli
Sixty-four consecutive patients with clinically or laboratory-supported definite multiple sclerosis (MS) were evaluated prospectively for evidence of primary Sjiigren's syndrome (SS). This diagnosis was established when a patient had objective keratoconjunctivitis sicca, xerostomia, or both together